HK1213050A1 - 作為 的診斷標誌物的微生物組抗體，應激因子和肥大細胞標誌物 - Google Patents

作為 的診斷標誌物的微生物組抗體，應激因子和肥大細胞標誌物

Info

Publication number
HK1213050A1
HK1213050A1 HK16100851.0A HK16100851A HK1213050A1 HK 1213050 A1 HK1213050 A1 HK 1213050A1 HK 16100851 A HK16100851 A HK 16100851A HK 1213050 A1 HK1213050 A1 HK 1213050A1
Authority
HK
Hong Kong
Prior art keywords
ibs
markers
microbiome
antibodies
mast cell
Prior art date
Application number
HK16100851.0A
Other languages
English (en)
Inventor
Sharat Singh
Ling Nicholas Chi-Kwan
Shui-Long Wang
Fred Princen
Stefan Westin
Steven Lockton
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of HK1213050A1 publication Critical patent/HK1213050A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK16100851.0A 2012-10-05 2016-01-26 作為 的診斷標誌物的微生物組抗體，應激因子和肥大細胞標誌物 HK1213050A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261710574P 2012-10-05 2012-10-05
US201361871853P 2013-08-29 2013-08-29
PCT/IB2013/059045 WO2014053996A2 (en) 2012-10-05 2013-10-01 Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs

Publications (1)

Publication Number Publication Date
HK1213050A1 true HK1213050A1 (zh) 2016-06-24

Family

ID=49447585

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100851.0A HK1213050A1 (zh) 2012-10-05 2016-01-26 作為 的診斷標誌物的微生物組抗體，應激因子和肥大細胞標誌物

Country Status (10)

Country Link
US (1) US10184940B2 (zh)
EP (1) EP2904395B1 (zh)
JP (1) JP6329553B2 (zh)
CN (1) CN104884959B (zh)
AU (1) AU2013326133B2 (zh)
CA (1) CA2886991A1 (zh)
HK (1) HK1213050A1 (zh)
MX (1) MX360479B (zh)
SG (2) SG10201702773QA (zh)
WO (1) WO2014053996A2 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720250D0 (en) 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
WO2014184343A1 (en) * 2013-05-17 2014-11-20 Basf Se Process for preparing n-substituted 1h-pyrazole-5-carboxylic acid compounds and derivatives thereof
SG11201509370UA (en) 2013-05-24 2015-12-30 Nestec Sa Pathway specific assays for predicting irritable bowel syndrome diagnosis
AU2016349703A1 (en) 2015-11-06 2018-11-01 Vetica Labs, Inc. Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
CA3010042A1 (en) * 2017-06-29 2018-12-29 Tata Consultancy Services Limited Method and system for monitoring the gut health of an individual
AU2018346255A1 (en) * 2017-10-03 2020-04-23 Seres Therapeutics, Inc. Manipulation of tryptamine metabolism
JP6533930B1 (ja) * 2018-08-23 2019-06-26 一般社団法人日本農業フロンティア開発機構 疾病評価指標算出方法、装置、システム、及び、プログラム、並びに、疾病評価指標を算出するためのモデル作成方法。
US11884958B2 (en) 2019-04-30 2024-01-30 Mayo Foundation For Medical Education And Research Assessing and treating functional gastrointestinal disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004048600A2 (en) * 2002-11-22 2004-06-10 Emory University Diagnostic tests and methods for diagnosing inflammatory bowel disease
US20060154276A1 (en) * 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US7943328B1 (en) * 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
JP5818793B2 (ja) * 2009-09-01 2015-11-18 イオン メディックス インコーポレイテッド 腸内共生細菌由来細胞外ベシクル、並びにこれを用いた疾病モデル、ワクチン、候補薬物探索方法及び診断方法
AU2010313292A1 (en) * 2009-10-30 2012-06-07 Nestec S.A. Methods for diagnosing irritable bowel syndrome

Also Published As

Publication number Publication date
SG10201702773QA (en) 2017-06-29
WO2014053996A2 (en) 2014-04-10
SG11201502641YA (en) 2015-05-28
US10184940B2 (en) 2019-01-22
MX2015004271A (es) 2015-08-14
CA2886991A1 (en) 2014-04-10
AU2013326133A1 (en) 2015-04-23
AU2013326133B2 (en) 2019-07-04
WO2014053996A3 (en) 2014-05-30
JP6329553B2 (ja) 2018-05-23
JP2015533213A (ja) 2015-11-19
CN104884959A (zh) 2015-09-02
EP2904395B1 (en) 2018-09-05
CN104884959B (zh) 2017-12-01
EP2904395A2 (en) 2015-08-12
US20150346200A1 (en) 2015-12-03
MX360479B (es) 2018-11-05

Similar Documents

Publication Publication Date Title
IL288256A (en) Digital to biological converter
HK1251033A1 (zh) 全細胞分析和方法
IL235128A0 (en) Preparation of a sample of nucleic acids
HK1213050A1 (zh) 作為 的診斷標誌物的微生物組抗體，應激因子和肥大細胞標誌物
SG11201500313YA (en) Single cell analysis using sequence tags
HK1198638A1 (zh) 樣品處理系統
EP2844768A4 (en) DIGITAL ANALYSIS OF ANALYTES
EP2852687A4 (en) METHODS FOR PREPARING A SAMPLE
HRP20170937T1 (hr) Postupci za identifikaciju antitijela smanjene imunogenosti
HK1207121A1 (zh) 細胞培養裝置
EP2937687A4 (en) sample injector
EP2904382A4 (en) HIGH SHAPE FACTOR STRUCTURE ANALYSIS
SG10201700670WA (en) Cell culture
EP2844773A4 (en) ANALYSIS OF BIOMARKERS USING SCODAPHORESIS
EP2844272A4 (en) METHOD AND COMPOSITIONS FOR INCREASING RED BLOOD BODIES
EP2928294A4 (en) CELL METHOD
EP2872652A4 (en) DEVICES AND METHODS FOR PREPARING AND ANALYZING NUCLEIC ACIDS
EP2753629A4 (en) SAMPLE PREPARATION PROCESS
GB201212550D0 (en) B cell assay
EP2843042A4 (en) CELL PREPARATION CONTAINING AN ENGAGED MYOCARDIAL CELL
EP2811014A4 (en) CELL COLLECTION PROCEDURES
GB201211873D0 (en) Cell culture
TWM443851U (en) Biological test chip
GB201316110D0 (en) Phenylboronic Acid
GB201213473D0 (en) Stress concentration reduction construction

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231001